Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4558381000168118 | Adakveo (crizanlizumab 100 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4558391000168115 | Adakveo 100 mg/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Adakveo 100 mg/10 mL injection, 10 mL vial | Is a | Adakveo | true | Inferred relationship | Some | ||
| Adakveo 100 mg/10 mL injection, 10 mL vial | Is a | crizanlizumab 100 mg/10 mL injection, vial | true | Inferred relationship | Some | ||
| Adakveo 100 mg/10 mL injection, 10 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Adakveo 100 mg/10 mL injection, 10 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Adakveo 100 mg/10 mL injection, 10 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1122653469 | |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has intended active ingredient | crizanlizumab | true | Inferred relationship | Some | 1227996182 | |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has Australian BoSS | crizanlizumab | true | Inferred relationship | Some | 1227996182 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has TPUU | True | Adakveo 100 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 932195270 |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has TPUU | True | Adakveo 100 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1710463619 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR